Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ritu Banerjee

Showing results (91-100 of 140) with videos related to

Pageof 14
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 18, 2021
Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TNLauren S Peetluk, Peter F Rebeiro, Kathryn M Edwards, et al.
Infection Control and Hospital Epidemiology|August 7, 2013
Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern communityRitu Banerjee, Jacob Strahilevitz, James R Johnson, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010Ritu Banerjee, Ari Robicsek, Michael A Kuskowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2015
Reply to Idelevich and BeckRitu Banerjee, Christine B Teng, Scott A Cunningham, et al.
Pediatric Blood & Cancer|December 19, 2023
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patientsDaniel A Whitehurst, Debra L Friedman, Zhiguo Zhao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2021
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health AdministrationFederico Perez, Roberto Viau Colindres, Brigid M Wilson, et al.
Pediatric Research|March 11, 2026
Comparing procalcitonin and C-reactive protein levels in very low birth weight infants with sepsisTess Stopczynski, Samantha Eschborn, Dorianna C Dobson, et al.
The Journal of Pediatrics|June 18, 2021
Low In-School COVID-19 Transmission and Asymptomatic Infection Despite High Community PrevalenceSophie E Katz, Rendie McHenry, Lauren G Mauer, et al.
Journal of the Pediatric Infectious Diseases Society|July 26, 2024
Durations of Antibiotic Treatment for Acute Otitis Media and Variability in Prescribed Durations Across Two Large Academic Health SystemsSophie E Katz, Timothy C Jenkins, Amy B Stein, et al.
Infectious Diseases and Therapy|July 1, 2019
Agreement Between Two Procalcitonin Assays in Hospitalized ChildrenSophie E Katz, Laura F Sartori, Andras Szeles, et al.
Pageof 14

Showing results (91-100 of 140) with videos related to

Sort By:
Pageof 14
Medrxiv : the Preprint Server for Health Sciences|November 18, 2021
Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TNLauren S Peetluk, Peter F Rebeiro, Kathryn M Edwards, et al.
Infection Control and Hospital Epidemiology|August 7, 2013
Predictors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli infection in a Midwestern communityRitu Banerjee, Jacob Strahilevitz, James R Johnson, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010Ritu Banerjee, Ari Robicsek, Michael A Kuskowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2015
Reply to Idelevich and BeckRitu Banerjee, Christine B Teng, Scott A Cunningham, et al.
Pediatric Blood & Cancer|December 19, 2023
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patientsDaniel A Whitehurst, Debra L Friedman, Zhiguo Zhao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2021
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT) Reveals Improvements in the Treatment of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae in Patients from the Veterans Health AdministrationFederico Perez, Roberto Viau Colindres, Brigid M Wilson, et al.
Pediatric Research|March 11, 2026
Comparing procalcitonin and C-reactive protein levels in very low birth weight infants with sepsisTess Stopczynski, Samantha Eschborn, Dorianna C Dobson, et al.
The Journal of Pediatrics|June 18, 2021
Low In-School COVID-19 Transmission and Asymptomatic Infection Despite High Community PrevalenceSophie E Katz, Rendie McHenry, Lauren G Mauer, et al.
Journal of the Pediatric Infectious Diseases Society|July 26, 2024
Durations of Antibiotic Treatment for Acute Otitis Media and Variability in Prescribed Durations Across Two Large Academic Health SystemsSophie E Katz, Timothy C Jenkins, Amy B Stein, et al.
Infectious Diseases and Therapy|July 1, 2019
Agreement Between Two Procalcitonin Assays in Hospitalized ChildrenSophie E Katz, Laura F Sartori, Andras Szeles, et al.
Pageof 14